Departments of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan.
Weight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, Tokyo, Japan.
Obes Surg. 2019 Feb;29(2):534-541. doi: 10.1007/s11695-018-3539-7.
The Asia-Pacific Metabolic and Bariatric Surgery Society (APMBSS) held its congress in Tokyo at the end of March, 2018, and representatives from Asia-Pacific countries presented the current status of bariatric/metabolic surgery in the "National Reports" session. The data are summarized here to show the current status and problems in the Asia-Pacific region in 2017.
A questionnaire including data of 2016 and 2017 and consisting of eight general questions was prepared and sent to representatives in 18 Asia-Pacific countries by e-mail before the congress. After the congress, the data were analyzed and summarized.
Seventeen of 18 countries responded to the survey. The frequency of obesity (BMI ≥ 30) in the 4 Gulf countries was > 30%, much higher than that in the other countries. In total, 1640 surgeons and 869 institutions were engaging in bariatric/metabolic surgery. In many East and Southeast Asian countries, the indication for bariatric surgery was BMI ≥ 35 or ≥ 37, whereas in many Gulf countries and Australia, it was BMI ≥ 40 or ≥ 35 with obesity-related disease. Ten of the 17 countries (58.8%) but only one of the 5 Southeast Asian countries (20.0%) had public health insurance coverage for bariatric surgery. In 2017, 95,125 patients underwent bariatric/metabolic surgery, with sleeve gastrectomy accounting for 68.0%, bypass surgery for 19.5%, and others for 12.5%. Current problems included public insurance coverage, training system, national registry, and lack of awareness and comprehension.
This summary showed that bariatric/metabolic surgery is rapidly developing along with various problems in Asia-Pacific countries.
亚太代谢与减重外科学会(APMBSS)于 2018 年 3 月底在东京举行大会,来自亚太国家的代表在“国家报告”环节展示了减重/代谢手术的现状。现将这些数据汇总,以展示 2017 年亚太地区的现状和问题。
会前通过电子邮件向 18 个亚太国家的代表发送了一份包含 2016 年和 2017 年数据的问卷,问卷由 8 个一般性问题组成。大会后对数据进行分析和总结。
18 个国家中有 17 个国家对调查做出了回应。4 个海湾国家的肥胖(BMI≥30)发病率超过 30%,远高于其他国家。共有 1640 名外科医生和 869 家机构从事减重/代谢手术。在许多东亚和东南亚国家,减重手术的适应证为 BMI≥35 或≥37,而在许多海湾国家和澳大利亚,BMI≥40 或 BMI≥35 合并肥胖相关疾病也可作为适应证。17 个国家中有 10 个(58.8%)、而 5 个东南亚国家中仅有 1 个(20.0%)有公共健康保险覆盖减重手术。2017 年,95125 名患者接受了减重/代谢手术,其中袖状胃切除术占 68.0%,旁路手术占 19.5%,其他手术占 12.5%。目前存在的问题包括公共保险覆盖范围、培训体系、国家登记处,以及缺乏意识和理解。
本总结表明,随着亚太国家各种问题的出现,减重/代谢手术正在迅速发展。